Eating Disorders in Women: Types, Warning Signs, and Care

Eating disorders are serious, potentially life-threatening mental health and medical conditions that affect women at disproportionate rates across all age groups. This page covers the major diagnostic categories recognized by the American Psychiatric Association, the physiological and psychological mechanisms involved, the warning signs clinicians and individuals close to affected women watch for, and the structured frameworks that guide clinical decision-making. Understanding these conditions within a health framework is relevant to broader women's health topics covered across this resource, including mental health, bone health, and reproductive function.

Definition and scope

The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) classifies eating disorders as a distinct category of psychiatric conditions characterized by persistent disturbances in eating behaviors and related thoughts and emotions that impair physical health or psychosocial functioning. The DSM-5 recognizes four primary diagnoses of clinical significance for women: anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and avoidant/restrictive food intake disorder (ARFID).

According to the National Eating Disorders Association (NEDA), an estimated 28.8 million Americans will experience an eating disorder at some point in their lifetime (NEDA, Eating Disorder Statistics). Women are diagnosed with anorexia nervosa and bulimia nervosa at rates approximately 3 times higher than men, per data cited by the National Institute of Mental Health (NIMH, Eating Disorders).

Federal regulatory oversight of eating disorder care intersects with mental health parity law. The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) requires that mental health benefits — including eating disorder treatment — not be subject to more restrictive coverage limits than medical or surgical benefits. The regulatory context governing women's health care access, including parity enforcement, shapes how eating disorder treatment is covered and delivered.

Eating disorders carry the highest mortality rate of any mental health condition. Anorexia nervosa specifically has an estimated crude mortality rate of approximately 5.9% per decade of illness, based on a meta-analysis published in Archives of General Psychiatry and cited by NIMH.

How it works

Each eating disorder diagnosis involves a distinct pattern of behavioral, cognitive, and physiological disruption.

Anorexia Nervosa (AN) is defined by restriction of energy intake relative to requirements, intense fear of weight gain, and distorted body image. The DSM-5 specifies two subtypes:
1. Restricting type — weight loss achieved through dieting, fasting, or excessive exercise, without recurrent binge or purge episodes.
2. Binge-eating/purging type — restriction combined with recurrent binge eating or purging behaviors within the prior 3 months.

Physiological consequences of AN include bradycardia, hypotension, electrolyte imbalances, bone density loss (clinically significant osteoporosis by DEXA scan criteria in women with prolonged illness), and amenorrhea — though the DSM-5 removed amenorrhea as a required criterion in 2013.

Bulimia Nervosa (BN) involves recurrent episodes of binge eating followed by compensatory behaviors (purging via vomiting, laxative misuse, or excessive exercise), occurring at a minimum average frequency of once per week for 3 months per DSM-5 criteria. Unlike AN, body weight in BN is often within a normal range, which delays clinical recognition. Electrolyte abnormalities, esophageal damage, and dental erosion are characteristic medical findings.

Binge Eating Disorder (BED) — first formally recognized as a standalone diagnosis in DSM-5 — is characterized by recurrent episodes of eating large amounts in a discrete period with a sense of loss of control, without recurrent compensatory behaviors. BED is the most prevalent eating disorder in the US adult population, per NIMH data.

ARFID involves avoidance or restriction of food intake based on sensory properties or anticipated negative consequences, not body image concerns, and is not better explained by a medical or cultural factor.

Common scenarios

Eating disorders in women present across distinct life-stage contexts, each with characteristic risk profiles:

Decision boundaries

Clinical decision-making in eating disorder care is structured around severity thresholds and level-of-care criteria. The American Psychiatric Association publishes Practice Guidelines for Eating Disorders, which define four levels of care:

  1. Outpatient treatment — appropriate when medical stability is maintained, weight is not critically low, and motivation for treatment is sufficient.
  2. Intensive outpatient program (IOP) — typically 9 or more hours of structured programming per week; indicated when outpatient care has been insufficient.
  3. Partial hospitalization program (PHP) — 20 or more hours per week; used when medical monitoring is needed but 24-hour supervision is not yet required.
  4. Inpatient or residential treatment — required when medical instability is present (e.g., heart rate below 50 beats per minute, electrolyte levels outside safe range, or body weight below 85% of expected).

Body mass index (BMI) thresholds, while historically used, are recognized as insufficient alone by the DSM-5 and APA guidelines. The National Alliance for Eating Disorders and the Academy for Eating Disorders both emphasize that medical severity must be assessed alongside behavioral frequency, psychiatric risk, and functional impairment. For a broader map of the health conditions related to eating disorders in women, including mental health, bone health, and nutrition, those topics extend the clinical picture.

References


The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)